Fylde Coast Clinical Research Limited in Chorley, PR7 1LD

Description

Data updated on: 01-11-2023

The official moment the company was registered is February 8, 2008. Registered under no. 06498820, this company is registered as a Private Limited Company. You may find the main office of this firm during office hours under the following address: John Goulding & Co 4 Southport Road, PR7 1LD Chorley. The company's declared SIC number is 86210 and has the NACE code: General medical practice activities. Fylde Coast Clinical Research Ltd reported its latest accounts for the financial year up to March 30, 2022. The business latest confirmation statement was released on February 8, 2023.

From the information we have gathered, the following limited company was formed 16 years ago and has so far been steered by eight directors, and out this collection of individuals two (Rebecca C. and Sarah S.) are still participating in the company's duties.

Executives who control the firm include: Sarah S. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Rebecca C. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-30	2017-03-31	2018-03-30	2019-03-30	2020-03-30	2021-03-30	2022-03-30	2023-03-30
Currency
Net Worth	327 460	260 900	118 931	95 660

Balance Sheet
Cash Bank On Hand				9 599	6 451	6 451	18 307	15 225	26 762	17 208	18 040	74 704
Current Assets	193 909	158 212	37 967	41 538	45 803	45 803	64 047	58 748	139 785	130 208	131 040	996 445
Debtors	161 458	125 427	33 620	31 939	39 352	8 319	45 740	43 523	113 023	113 000	113 000	921 741
Net Assets Liabilities									70 811	80 022	79 244	766 136
Other Debtors				1 302			16 873	15 023	84 523	84 500	84 500	893 241
Property Plant Equipment								2 153	1 435	10 202	6 323	3 161
Cash Bank In Hand	32 451	32 785	4 347	9 599
Intangible Fixed Assets	150 000	120 000	90 000	60 000
Net Assets Liabilities Including Pension Asset Liability	327 460	260 900

Capital & Reserves
Called Up Share Capital	100	100	100	100
Profit Loss Account Reserve	327 360	260 800	118 831	95 560
Shareholder Funds	327 460	260 900	118 931	95 660

Other Financial Data
Accumulated Amortisation Impairment Intangible Assets				240 000	270 000	270 000	300 000	300 000	300 000	300 000	300 000
Accumulated Depreciation Impairment Property Plant Equipment								718	1 436	5 314	9 193	12 355
Average Number Employees During Period								2	2	2	2	2
Corporation Tax Payable								1 953	16 020	6 728
Creditors				5 879	6 177	6 177	63 947	57 662	70 409	58 450	56 918	232 870
Deferred Tax Asset Debtors				24 000	31 033	31 033	28 867	28 500	28 500	28 500	28 500	28 500
Future Minimum Lease Payments Under Non-cancellable Operating Leases										50 295	87 336	31 612
Increase From Amortisation Charge For Year Intangible Assets						30 000	30 000
Increase From Depreciation Charge For Year Property Plant Equipment								718	718	3 878	3 879	3 162
Intangible Assets				60 000	30 000	30 000
Intangible Assets Gross Cost				300 000	300 000		300 000	300 000	300 000	300 000	300 000
Net Current Assets Liabilities	177 460	140 900	28 931	35 660	39 626	39 626	100	1 086	69 376	71 758	74 122	763 575
Number Shares Issued Fully Paid						100	100
Other Creditors				5 879	2 479	2 479	2 160	2 160	840	19 173	56 481	71 146
Other Taxation Social Security Payable										6 728	437	161 724
Par Value Share		1	1	1		1	1
Property Plant Equipment Gross Cost								2 871	2 871	15 516	15 516
Provisions For Liabilities Balance Sheet Subtotal										1 938	1 201	600
Total Additions Including From Business Combinations Property Plant Equipment								2 871		12 645
Total Assets Less Current Liabilities	327 460	260 900	118 931	95 660	69 626	69 626	100	3 239	70 811	81 960	80 445	766 736
Trade Creditors Trade Payables					3 698	3 698	61 787	53 549	53 549	32 549
Trade Debtors Trade Receivables				6 638	8 319	8 319
Creditors Due Within One Year	16 449	17 312	9 036	5 878
Number Shares Allotted		100	100	100
Fixed Assets	150 000	120 000
Intangible Fixed Assets Aggregate Amortisation Impairment	150 000	180 000
Intangible Fixed Assets Amortisation Charged In Period		30 000
Intangible Fixed Assets Cost Or Valuation	300 000	300 000
Share Capital Allotted Called Up Paid	100	100	100	100
Amount Specific Advance Or Credit Directors	27 576	23 734

Company staff

Rebecca C.

Role: Director

Appointed: 17 December 2012

Latest update: 5 April 2024

Sarah S.

Role: Director

Appointed: 17 December 2012

Latest update: 5 April 2024

Jerome K.

Role: Director

Appointed: 01 February 2013

Resigned: 31 July 2016

Latest update: 5 April 2024

Rebecca C.

Role: Director

Appointed: 17 December 2012

Resigned: 17 December 2012

Latest update: 5 April 2024

Joan H.

Role: Director

Appointed: 15 December 2011

Resigned: 17 December 2012

Latest update: 5 April 2024

Carol K.

Role: Director

Appointed: 15 December 2011

Resigned: 31 July 2016

Latest update: 5 April 2024

Jerome K.

Role: Director

Appointed: 08 February 2008

Resigned: 09 May 2013

Latest update: 5 April 2024

Joan H.

Role: Secretary

Appointed: 08 February 2008

Resigned: 17 December 2012

Latest update: 5 April 2024

David H.

Role: Director

Appointed: 08 February 2008

Resigned: 17 December 2012

Latest update: 5 April 2024

People with significant control

Sarah S.

Notified on 31 July 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Rebecca C.

Notified on 31 July 2016

Nature of control:

1/2 or less of voting rights

1/2 or less of shares

Accounts Documents

Account next due date	30 December 2023
Account last made up date	30 March 2022
Confirmation statement next due date	22 February 2024
Confirmation statement last made up date	08 February 2023

Annual Accounts 22 December 2014
Start Date For Period Covered By Report	2013-04-01
End Date For Period Covered By Report	2014-03-31
Date Approval Accounts	22 December 2014
Annual Accounts 17 December 2015
Start Date For Period Covered By Report	2014-04-01
End Date For Period Covered By Report	2015-03-31
Date Approval Accounts	17 December 2015
Annual Accounts 23 December 2016
Start Date For Period Covered By Report	2015-04-01
End Date For Period Covered By Report	2016-03-31
Date Approval Accounts	23 December 2016
Annual Accounts
Start Date For Period Covered By Report	2016-04-01
End Date For Period Covered By Report	2017-03-31
Annual Accounts
Start Date For Period Covered By Report	2017-03-31
End Date For Period Covered By Report	2018-03-30
Annual Accounts
Start Date For Period Covered By Report	2018-03-31
End Date For Period Covered By Report	2019-03-30
Annual Accounts
Start Date For Period Covered By Report	2019-03-31
End Date For Period Covered By Report	2020-03-30
Annual Accounts
Start Date For Period Covered By Report	2020-03-31
End Date For Period Covered By Report	2021-03-30
Annual Accounts
Start Date For Period Covered By Report	2021-03-31
End Date For Period Covered By Report	2022-03-30
Annual Accounts
Start Date For Period Covered By Report	2022-03-31
End Date For Period Covered By Report	2023-03-30

Fylde Coast Clinical Research Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Rebecca C.

Sarah S.

Jerome K.

Rebecca C.

Joan H.

Carol K.

Jerome K.

Joan H.

David H.

People with significant control

Sarah S.

Rebecca C.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies